Assembly Biosciences, Inc. (ASMB)Healthcare | Biotechnology | South San Francisco, United States | NasdaqGS
29.24 USD
-0.08
(-0.273%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 29.24 Short-term: ★★★★☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:28 p.m. EDT
ASMB presents a compelling 'bottom-fish' opportunity in a biotech that has recently received a catalyst boost (HSV drug results) but is trading well below analyst consensus targets (Range: 40-62, Mean: 48.75). While the company remains unprofitable with negative margins, the balance sheet is incredibly strong with minimal debt and a current ratio of 5.2, implying a very low risk of bankruptcy in the near term. The technicals show a bounce from the 52-week low, and options market positioning is bullish, pricing in continued recovery to the upside. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.046655 |
| AutoETS | 0.047145 |
| MSTL | 0.048222 |
| AutoTheta | 0.103228 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 72% |
| H-stat | 1.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.088 |
| Excess Kurtosis | -0.49 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.271 |
| Revenue per Share | 6.449 |
| Market Cap | 463,825,504 |
| Forward P/E | -12.66 |
| Beta | 1.16 |
| Profit Margins | -8.47% |
| Website | https://www.assemblybio.com |
As of April 18, 2026, 10:28 p.m. EDT: Options flow shows a significant bullish skew. Call Open Interest (OI) is heavily concentrated in OTM strikes for June (40 strike) and September (45 strike), indicating speculator positioning for upside beyond the current price. The largest net OI gain is in OTM calls (June 40 strike and Sept 45 strike). Conversely, PUT OI is negligible and concentrated deep ITM, suggesting minimal hedging demand. Open Interest has effectively vanished for near-term OTM calls (May 15 25/30 strikes), meaning the current signal is driven by new entry into longer-dated upside structures. Overall momentum is clearly directional to the upside.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.9416499 |
| Address1 | Two Tower Place |
| Address2 | 7th Floor |
| All Time High | 1,260.0 |
| All Time Low | 7.68 |
| Ask | 29.85 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 124,210 |
| Average Daily Volume3 Month | 98,717 |
| Average Volume | 98,717 |
| Average Volume10Days | 124,210 |
| Beta | 1.158 |
| Bid | 28.64 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 13.04 |
| City | South San Francisco |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 29.24 |
| Current Ratio | 5.218 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 30.19 |
| Day Low | 28.8 |
| Debt To Equity | 1.271 |
| Display Name | Assembly Biosciences |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,510,400 |
| Ebitda | -11,989,000 |
| Ebitda Margins | -0.16582 |
| Enterprise To Ebitda | -18.212 |
| Enterprise To Revenue | 3.02 |
| Enterprise Value | 218,347,488 |
| Eps Current Year | -1.22667 |
| Eps Forward | -2.31 |
| Eps Trailing Twelve Months | -0.55 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 28.4502 |
| Fifty Day Average Change | 0.78980064 |
| Fifty Day Average Change Percent | 0.027760813 |
| Fifty Two Week Change Percent | 194.165 |
| Fifty Two Week High | 39.71 |
| Fifty Two Week High Change | -10.469999 |
| Fifty Two Week High Change Percent | -0.26366153 |
| Fifty Two Week Low | 9.82 |
| Fifty Two Week Low Change | 19.42 |
| Fifty Two Week Low Change Percent | 1.9775968 |
| Fifty Two Week Range | 9.82 - 39.71 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,292,596,200,000 |
| Float Shares | 7,490,528 |
| Forward Eps | -2.31 |
| Forward P E | -12.658009 |
| Free Cashflow | -4,983,750 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 73 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.103590004 |
| Gross Profits | 7,490,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.32206002 |
| Held Percent Institutions | 0.59943 |
| Implied Shares Outstanding | 15,862,705 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,707,696,000 |
| Last Split Factor | 1:12 |
| Long Business Summary | Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. |
| Long Name | Assembly Biosciences, Inc. |
| Market | us_market |
| Market Cap | 463,825,504 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_99715344 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -6,122,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 463,825,494 |
| Number Of Analyst Opinions | 4 |
| Open | 29.91 |
| Operating Cashflow | -41,093,000 |
| Operating Margins | 0.4662 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Phone | 833 509 4583 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 29.24 |
| Post Market Time | 1,776,456,604 |
| Previous Close | 29.32 |
| Price Eps Current Year | -23.836891 |
| Price Hint | 2 |
| Price To Book | 2.2423313 |
| Price To Sales Trailing12 Months | 6.4150243 |
| Profit Margins | -0.08467 |
| Quick Ratio | 5.137 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0799999 |
| Regular Market Change Percent | -0.272851 |
| Regular Market Day High | 30.19 |
| Regular Market Day Low | 28.8 |
| Regular Market Day Range | 28.8 - 30.19 |
| Regular Market Open | 29.91 |
| Regular Market Previous Close | 29.32 |
| Regular Market Price | 29.24 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 229,833 |
| Return On Assets | -0.0402 |
| Return On Equity | -0.05099 |
| Revenue Growth | 4.773 |
| Revenue Per Share | 6.449 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 15,862,705 |
| Shares Percent Shares Out | 0.096599996 |
| Shares Short | 1,533,102 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,479,082 |
| Short Name | Assembly Biosciences, Inc. |
| Short Percent Of Float | 0.113199994 |
| Short Ratio | 20.26 |
| Source Interval | 15 |
| State | CA |
| Symbol | ASMB |
| Target High Price | 62.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 48.75 |
| Target Median Price | 46.5 |
| Total Cash | 248,106,000 |
| Total Cash Per Share | 15.641 |
| Total Debt | 2,628,000 |
| Total Revenue | 72,303,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.55 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 27.69335 |
| Two Hundred Day Average Change | 1.5466499 |
| Two Hundred Day Average Change Percent | 0.055849146 |
| Type Disp | Equity |
| Volume | 229,833 |
| Website | https://www.assemblybio.com |
| Zip | 94,080 |